Ekso Bionics Holdings, Inc. (EKSO)
USD 0.63
(-11.99%)
USD 0.63
(-11.99%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -15.19 Million USD | -4.07% |
| 2022 | -14.6 Million USD | -73.2% |
| 2021 | -8.43 Million USD | 50.27% |
| 2020 | -16.95 Million USD | -44.98% |
| 2019 | -11.69 Million USD | 56.68% |
| 2018 | -26.99 Million USD | 7.31% |
| 2017 | -29.12 Million USD | -24.08% |
| 2016 | -23.47 Million USD | -19.81% |
| 2015 | -19.59 Million USD | 41.99% |
| 2014 | -33.76 Million USD | -274623.4% |
| 2013 | -12.29 Thousand USD | 99.92% |
| 2012 | -15.04 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.41 Million USD | 29.54% |
| 2024 Q3 | -2.07 Million USD | 14.24% |
| 2024 Q1 | -3.42 Million USD | -6.69% |
| 2023 Q3 | -3.36 Million USD | 20.45% |
| 2023 Q4 | -3.21 Million USD | 4.49% |
| 2023 FY | -15.19 Million USD | -4.07% |
| 2023 Q1 | -4.19 Million USD | -104.58% |
| 2023 Q2 | -4.23 Million USD | -0.76% |
| 2022 Q4 | -2.05 Million USD | 58.58% |
| 2022 FY | -14.6 Million USD | -73.2% |
| 2022 Q1 | -5 Million USD | -74.75% |
| 2022 Q3 | -4.95 Million USD | -81.66% |
| 2022 Q2 | -2.72 Million USD | 45.49% |
| 2021 Q4 | -2.86 Million USD | -46.22% |
| 2021 Q3 | -1.95 Million USD | -53.81% |
| 2021 Q2 | -1.27 Million USD | 65.31% |
| 2021 Q1 | -3.67 Million USD | 7.7% |
| 2021 FY | -8.43 Million USD | 50.27% |
| 2020 Q2 | -11.76 Million USD | -364.36% |
| 2020 Q4 | -3.97 Million USD | -262.15% |
| 2020 Q3 | 2.45 Million USD | 120.84% |
| 2020 FY | -16.95 Million USD | -44.98% |
| 2020 Q1 | -2.53 Million USD | 6.94% |
| 2019 Q3 | 206 Thousand USD | 106.72% |
| 2019 Q1 | -6.55 Million USD | -58.58% |
| 2019 Q2 | -3.06 Million USD | 53.2% |
| 2019 Q4 | -2.72 Million USD | -1421.84% |
| 2019 FY | -11.69 Million USD | 56.68% |
| 2018 Q2 | -7.97 Million USD | -0.97% |
| 2018 FY | -26.99 Million USD | 7.31% |
| 2018 Q4 | -4.13 Million USD | 40.84% |
| 2018 Q3 | -6.98 Million USD | 12.47% |
| 2018 Q1 | -7.9 Million USD | 12.0% |
| 2017 Q3 | -6.33 Million USD | -15.04% |
| 2017 Q4 | -8.97 Million USD | -41.72% |
| 2017 FY | -29.12 Million USD | -24.08% |
| 2017 Q1 | -8.3 Million USD | -48.89% |
| 2017 Q2 | -5.5 Million USD | 33.67% |
| 2016 Q2 | -5.76 Million USD | -57.9% |
| 2016 FY | -23.47 Million USD | -19.81% |
| 2016 Q4 | -5.57 Million USD | 34.23% |
| 2016 Q3 | -8.47 Million USD | -47.06% |
| 2016 Q1 | -3.65 Million USD | 21.4% |
| 2015 Q1 | -4.11 Million USD | 79.58% |
| 2015 FY | -19.59 Million USD | 41.99% |
| 2015 Q4 | -4.64 Million USD | 10.41% |
| 2015 Q3 | -5.18 Million USD | 8.15% |
| 2015 Q2 | -5.64 Million USD | -37.18% |
| 2014 Q3 | 12.02 Million USD | -78.58% |
| 2014 Q2 | 56.12 Million USD | 168.64% |
| 2014 Q1 | -81.76 Million USD | -1345831.84% |
| 2014 FY | -33.76 Million USD | -274623.4% |
| 2014 Q4 | -20.15 Million USD | -267.62% |
| 2013 FY | -12.29 Thousand USD | 99.92% |
| 2013 Q4 | -6075.00 USD | -306.9% |
| 2013 Q1 | -4368.00 USD | -145.81% |
| 2013 Q2 | -23.19 Thousand USD | -431.0% |
| 2013 Q3 | -1493.00 USD | 93.56% |
| 2012 Q3 | -1252.00 USD | 74.42% |
| 2012 FY | -15.04 Million USD | 0.0% |
| 2012 Q2 | -4895.00 USD | 0.0% |
| 2012 Q4 | -1777.00 USD | -41.93% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 75.999% |
| AngioDynamics, Inc. | -184.34 Million USD | 91.756% |
| AtriCure, Inc. | -30.43 Million USD | 50.069% |
| Avinger, Inc. | -18.32 Million USD | 17.041% |
| Azenta, Inc. | -14.25 Million USD | -6.6% |
| BioLife Solutions, Inc. | -66.42 Million USD | 77.121% |
| The Cooper Companies, Inc. | 294.2 Million USD | 105.166% |
| Daxor Corporation | 280.64 Thousand USD | 5515.479% |
| Femasys Inc. | -14.24 Million USD | -6.674% |
| GlucoTrack, Inc. | -7.09 Million USD | -114.147% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -345.037% |
| Hologic, Inc. | 789.5 Million USD | 101.925% |
| ICU Medical, Inc. | -29.65 Million USD | 48.751% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.845% |
| KORU Medical Systems, Inc. | -13.74 Million USD | -10.603% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 150.483% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -128.081% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -128.081% |
| Masimo Corporation | 81.5 Million USD | 118.648% |
| Microbot Medical Inc. | -10.74 Million USD | -41.508% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 230.731% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 116.098% |
| Nephros, Inc. | -1.57 Million USD | -864.952% |
| NovoCure Limited | -207.04 Million USD | 92.659% |
| NEXGEL, Inc. | -3.15 Million USD | -381.406% |
| NEXGEL, Inc. | -3.15 Million USD | -381.406% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 83.972% |
| OraSure Technologies, Inc. | 53.65 Million USD | 128.325% |
| Pro-Dex, Inc. | 2.12 Million USD | 814.528% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 63.994% |
| Predictive Oncology Inc. | -13.98 Million USD | -8.682% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -414.946% |
| QuidelOrtho Corporation | -10.1 Million USD | -50.475% |
| Repligen Corporation | 41.57 Million USD | 136.554% |
| Sanara MedTech Inc. | -4.3 Million USD | -253.179% |
| STAAR Surgical Company | 21.34 Million USD | 171.195% |
| Sharps Technology, Inc. | -9.84 Million USD | -54.426% |
| Utah Medical Products, Inc. | 16.63 Million USD | 191.362% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 88.486% |
| Jin Medical International Ltd. | 2.87 Million USD | 628.033% |